Moderna announces new study showing its covid-19 vaccine maintains antibodies against variants of concern and interest to 6 months

Cambridge, mass.--(business wire)--moderna announces new study showing its covid-19 vaccine maintains antibodies against variants of concern and interest to 6 months.

MRNA Ratings Summary

MRNA Quant Ranking